0.16

10.11% -0.018

After Hours: .16

Matinas Biopharma Holdings Inc (MTNB)

Overview News Price History Discussions Forecast

Matinas Biopharma Holdings Inc stock is traded at $0.16, with a volume of 758.70K. It is down -10.11% in the last 24 hours and down -18.91% over the past month. Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.

Previous Close:

$0.178

Open:

$0.172

24h Volume:

758.70K

Relative Volume:

0.17

Market Cap:

$156.72K

Revenue:

$1.10M

Net Income/Loss:

$-11.23M

P/E Ratio:

-0.079

EPS:

-2.025

Net Cash Flow:

$-6.61M

1W Performance:

-0.25%

1M Performance:

-18.91%

6M Performance:

-71.93%

1Y Performance:

-91.49%

1-Day Range:

$0.1542

$0.1762

1-Week Range:

$0.1542

$0.1797

52-Week Range:

$0.1505

$1.99

Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile

Name

Matinas Biopharma Holdings Inc

Sector

Healthcare (1067)

Industry

Biotechnology (595)

Phone

908-443-1860

Address

1545 Route 206 South, Suite 302, Bedminster, NJ

Employee

Twitter

@MatinasBio

Next Earnings Date

2026-11-09

Latest SEC Filings

MTNB's Discussions on Twitter

Compare MTNB vs VRTX, REGN, MRNA, ARGX, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MTNB Matinas Biopharma Holdings Inc	0.16	156.72K	1.10M	-11.23M	-6.61M	-2.025
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-11-21	Downgrade	Piper Sandler	Overweight → Neutral
Aug-26-20	Resumed	Piper Sandler	Overweight
Jan-27-20	Initiated	Piper Sandler	Overweight
Jan-24-20	Initiated	SunTrust	Buy
Jan-23-20	Initiated	SunTrust	Buy
Jan-09-20	Initiated	Aegis Capital	Buy
Jun-26-19	Initiated	H.C. Wainwright	Buy

View All

Matinas Biopharma Holdings Inc Stock (MTNB) Latest News

Sep 17, 2026

Matinas BioPharma announces one-for-fifteen reverse stock split approval By Investing.com - Investing.com India

Sep 17, 2026

Sep 16, 2026

Matinas BioPharma announces one-for-fifteen reverse stock split approval - Investing.com

Sep 16, 2026

Form 8K Matinas BioPharma Holdings Inc For: 16 September By Investing.com - Investing.com Canada

Sep 16, 2026

Matinas BioPharma Announces One-for-Fifteen Reverse Stock Split - tipranks.com

Sep 16, 2026

Matinas BioPharma to implement 1-for-15 reverse stock split effective Sept. 28, 2026 - TradingView

Sep 16, 2026

Sep 14, 2026

A first commercial hydrogen deal covers up to 1,000 kilograms a day from GH Power’s facility. - Stock Titan

Sep 14, 2026

Sep 13, 2026

Price to sales forward of Matinas Biopharma Holdings, Inc. – BOATS:MTNB - TradingView

Sep 13, 2026

Sep 12, 2026

Matinas BioPharma Share PriceMTNB, RNS News, Articles, Quotes, & Charts (OTCMKTS:MTNB) - Proactive financial news

Sep 12, 2026

Sep 08, 2026

Matinas Biopharma (MTNB) Holds Steady at $0.18 as Key Support HoldsRVOL Breakout - dars.gov.et

Sep 08, 2026

Sep 07, 2026

Matinas BioPharma Faces NYSE American Compliance Challenges - TipRanks

Sep 07, 2026

Sep 04, 2026

Matinas BioPharma Receives New NYSE American Delisting Risk on Equity Shortfall - minichart.com.sg

Sep 04, 2026

Matinas BioPharma Receives NYSE American Noncompliance Notice for Continued Listing Standards - Quiver Quantitative

Sep 04, 2026

Matinas BioPharma Received Notice of Noncompliance - tradingview.com

Sep 04, 2026

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewswire

Sep 04, 2026

symbol__ Stock Quote Price and Forecast - CNN

Sep 04, 2026

Sep 03, 2026

MTNB Q4 2024 Earnings: Narrower-than-Expected Loss Still Overshadowed by Zero RevenueOne-Time Loss Impact - dars.gov.et

Sep 03, 2026

Aug 25, 2026

Matinas (MTNB) Results Review: EPS Lands Above Forecast in the Latest Reading; Closing Move: Shares Finish 1.16% Down at the ClosePerformance Review - vinanet.vn

Aug 25, 2026

Aug 24, 2026

Matinas (MTNB) Session: Finishes 1.16% Down at $0.20 on the Day; Levels: the Near-Term Reference Band Stretches From $0.19 to $0.21 in the Current UpdateWave Equality - vinanet.vn

Aug 24, 2026

Aug 23, 2026

Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingShare Repurchase Impact - vinanet.vn

Aug 23, 2026

Matinas (MTNB) Trading: Finishes 8.93% Higher at $0.20 in the Latest Session; Key Range: the Supplied Trading Band Runs From $0.19 to $0.21 under the Current SnapshotUnusual Put Volume - dars.gov.et

Aug 23, 2026

Aug 20, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Aug 20, 2026

Top Premarket Decliners - marketscreener.com

Aug 20, 2026

Aug 19, 2026

Matinas (MTNB) Results Review: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Market Response: The Stock Loses 8.33%Earnings Trend Analysis - vinanet.vn

Aug 19, 2026

Aug 16, 2026